Evaluating the Breakthrough Mentoring scheme: a feasibility pilot randomised control trial (RCT) with vulnerable adolescents deemed at risk of exclusion in a secondary school setting.

Mentoring vulnerable and excluded adolescents to achieve better health and well-being: A feasibility study and pilot randomised control trial (RCT) of the Breakthrough Mentoring Scheme.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN97394558

Enrollment

Registered

2015-09-08

Start date

2013-09-10

Completion date

Unknown

Last updated

2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vulnerable young people (11-16 years) engaging in multiple risk behaviours deemed at risk of exclusion by school staff. Mental and Behavioural Disorders

Interventions

Participants allocated to the intervention will receive Breakthrough mentoring for a school year in addition to any on-going support provided by the school. Control group participants

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Students aged 11-16 years identified by school staff members as pupils that would benefit from Breakthrough mentoring scheme.

Exclusion criteria

Exclusion criteria: Students will be excluded if they are either currently receiving or have received Breakthrough mentoring in the past.

Design outcomes

Primary

Measure	Time frame
This study will assess and evaluate the perceived helpfulness of the Breakthrough Mentoring Programme by conducting a qualitative process evaluation. It will also explore the feasibility of collecting data and estimating the parameters needed to design a definitive RCT. Measured at baseline, 6, 12 & 18 month follow-ups.	—

Secondary

Measure	Time frame
1. Strengths and Difficulties questionnaire (SDQ) 2. Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) 3. Social Connectedness Scale- Revised (SCS-R) 4. Questions about risk behaviour (sexual health, alcohol and drug taking) Assessed at the start of the study (baseline), 6, 12 and 18 months later	—

Countries

United Kingdom

Contacts

Public ContactAngela Beattie

angela.beattie@bristol.ac.uk+44(0)117 9287351

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026